Johnson & Johnson (JNJ) EVP Jennifer Taubert granted 27,412 performance share units

Rhea-AI Filing Summary

Johnson & Johnson executive Jennifer Taubert reported an equity award tied to performance. On February 9, 2026, she acquired 27,412 Performance Share Units (PSUs) at a price of $0. These PSUs were originally granted on February 13, 2023 under the company’s Long-Term Incentive Plan.

The 27,412 PSUs represent the target award adjusted based on achievement of performance conditions, which were certified on February 9, 2026. The PSUs convert into shares of Johnson & Johnson common stock upon vesting, so their ultimate value depends on both vesting and the company’s share price at that time.

Insights

Equity Compensation Analyst

Routine performance-based equity vesting for a senior Johnson & Johnson executive.

Jennifer Taubert, EVP, WWC. Innovative Medicine, acquired 27,412 Performance Share Units via a grant classified as a “Grant, award, or other acquisition.” The units stem from a February 13, 2023 long-term incentive award and were adjusted based on certified performance results on February 9, 2026.

The PSUs convert into Johnson & Johnson common stock upon vesting, at no exercise price, so they function as performance-based stock. This aligns executive pay with long-term company performance, but the filing does not indicate any open-market buying or selling of shares.

Future value depends on vesting of the 27,412 PSUs and the share price when they settle into common stock. Subsequent company filings may provide additional detail on realized compensation as awards vest and are delivered.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taubert Jennifer L

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, WWC. Innovative Medicine

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Units	(1)	02/09/2026		A		27,412		02/13/2026	(1)	Common Stock	27,412	$0	27,412(2)	D

Explanation of Responses:

1. Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.

2. The number of PSUs reflects the target number of PSUs originally granted on February 13, 2023, adjusted to reflect achievement relative to the performance conditions set forth in the award agreement, as certified on February 9, 2026.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Jennifer Taubert	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Johnson & Johnson (JNJ) report for Jennifer Taubert?

Johnson & Johnson reported that EVP Jennifer Taubert acquired 27,412 Performance Share Units on February 9, 2026. These units come from a 2023 long-term incentive grant and convert into common stock when vesting conditions are satisfied.

How many Performance Share Units did Jennifer Taubert receive in this Johnson & Johnson (JNJ) Form 4?

Jennifer Taubert received 27,412 Performance Share Units. This figure reflects the target PSUs from the February 13, 2023 grant, adjusted based on achievement of performance conditions certified on February 9, 2026 under the long-term incentive plan.

At what price were Jennifer Taubert’s Johnson & Johnson (JNJ) Performance Share Units granted?

The 27,412 Performance Share Units were granted at a price of $0 per unit. Because PSUs convert into common stock upon vesting, their economic value comes from the company’s share price at settlement rather than from any exercise price.

What is the origin of the Performance Share Units reported for Jennifer Taubert at Johnson & Johnson (JNJ)?

The PSUs were awarded under Johnson & Johnson’s Long-Term Incentive Plan on February 13, 2023. The reported 27,412 units represent the target number, adjusted after performance conditions in the award agreement were measured and certified on February 9, 2026.

When do Jennifer Taubert’s Johnson & Johnson (JNJ) Performance Share Units convert into common stock?

The Performance Share Units convert into Johnson & Johnson common stock upon vesting. The filing explains that PSUs awarded under the long-term incentive plan become common shares once vesting conditions and performance criteria specified in the award agreement are met.

Does this Johnson & Johnson (JNJ) Form 4 show any open-market stock sale or purchase by Jennifer Taubert?

The Form 4 shows an acquisition of 27,412 Performance Share Units as a grant, not an open-market trade. The transaction code indicates a grant or award, meaning it reflects equity compensation rather than buying or selling shares in the market.